ANT and the consensus view
Rainer Michael Preiss – Global Markets Commentary
Anthropic sold 980 million shares at $83, above its $70-to-$78 range, raising $81.3 billion in the largest IPO on human record. The stock opened about 34.3% above the IPO price, at $111.50. It closed the first day lower, at around $97.
Whether Anthropic can ride a volatile or smooth journey to price discovery will come under Wall Street’s human analysts microscope. Banks with human employees usually start official equity overage once the post-IPO quiet period ends, about 25 days after listing.
Analyst consensus so far: According to 5 analysts, the average rating is “Buy,” with a 12-month price target of $118.93, about 22% above the latest price. That average is based on very few analysts, so it will move.
ANT stock Individual targets (high to low):
Melius: $155 over two years, currently the highest target known to humans and LLM alike.
Needham (Scott Berg): Buy, $150. This values Anthropic at 18 times estimated fiscal 2027 revenue, or 81 times free cash flow.
William Blair: Outperform. It called the IPO valuation reasonable at nine times estimated 2027 sales and said 17 to 20 times sales could put the stock at $130 to $150.
Citizens: $125
New Street Research (Pierre Ferragu): Buy, $105
Freedom Kazakhstan and KGI Taiwan: Freedom $101.90 and KGI $100
More cautious views:
Morningstar: fair value of $92
Aswath Damodaran (NYU Stern): about $76, citing higher data center costs and regulatory pressure
Fundamentals behind the debate: The ANT company reported a 22% gross margin over the last 12 months and is still unprofitable. It also has $900.9 billion in purchase commitments and lease obligations, mainly for computing infrastructure, through 2045.
ANT current sell-side targets run from about $100 to $155 and are all BUY or Outperform so far. The independent valuations from Morningstar and Damodaran sit near or below the current stock price.
Smart money and family offices know and understand “just because it is consensus does not necessarily make it wrong. U.S legendary out outperforming equity fund manager Peter lynch from fidelity famously opined: “100,000 Frenchmen or analysts can still be wrong.”
Under Singapore law the legal disclaimer is that Mr. Lynch was a human and not an LLM
Consensus can be informative. It can also become self-reinforcing. Like AI regulation this requires good human judgment.
Rainer Michael Preiss, Partner & Portfolio Strategist DAS family Office


